|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online April 18, 2006
Journal of Experimental Biology 209, 1765-1776 (2006)
Published by The Company of Biologists 2006
doi: 10.1242/jeb.02152
Regulation of the mitogen-activated protein kinase p44 ERK activity during anoxia/recovery in rainbow trout hypodermal fibroblasts
Institute of Molecular Biology and Physiology, Department of Biochemistry, The August Krogh Building, University of Copenhagen, Universitetsparken 13, DK-2100 Copenhagen Ø, Denmark
* Author for correspondence (e-mail: cgossum{at}aki.ku.dk)
Accepted 7 February 2006
| Summary |
|---|
|
|
|---|
Key words: p38, MAPK, teleost, ROS, phosphatase, PP1, PP2A, calyculin A, hypoxia, recovery, SB203580
| Introduction |
|---|
|
|
|---|
It is well known from mammalian cells that anoxia has a major impact on the
mitogen-activated protein kinases, MAPKs. The MAPK family includes the
subfamilies ERK, p38MAPK and c-Jun N-terminal kinase (JNK). The
ERKs (Cowan and Storey, 2003
;
Schaeffer and Weber, 1999
)
respond to mitogens and survival signals and stimulate cell proliferation,
growth and survival. JNK (Barr and
Bogoyevitch, 2001
) and p38MAPK
(New and Han, 1998
) are mainly
activated by cellular stress. The interplay between the mitogenic and the
stress-activated MAPK pathways are considered critical for cell fate, as
sustained p38MAPK and JNK activity and suppression of ERK activity
result in apoptosis (Xia et al.,
1995
), whereas ERK1/2 can suppress apoptosis by phosphorylation of
Bad (Jin et al., 2002
) and
procaspase 9 (Allan et al.,
2003
).
MAPK pathways are generally thought of as three-kinase modules, consisting
of a MAP kinase kinase kinase (MAP3K) upstream of a MAPK kinase kinase
(MAP2K), which in turn activates the MAP kinase
(Kyriakis and Avruch, 2001
).
The MAP3Ks are often found downstream of small GTPases, such as Ras. This
opens up the possibility for a wide range of regulatory inputs, both at the
MAP3K level and at the level of MAP2K
(Widmann et al., 1999
).
Upstream of the mammalian MAPKs, ERK1 and ERK2, is Raf (MAP3K) and MAPK/ERK
kinase (MEK)1/2 (MAP2K). In vivo, ERK is typically activated
following activation of receptor protein tyrosine kinases, such as the
platelet-derived growth factor receptor and epidermal growth factor receptor
that in turn activate the small G protein Ras
(Widmann et al., 1999
).
Regulation of the stress-responsive MAP-kinases p38MAPK and JNK are
far more complex (Kyriakis and Avruch,
2001
) owing to the presence of multiple MAP3Ks and two different
MAP2Ks regulating the kinases, MKK3/6 and MKK4/7 for p38MAPK and
JNK, respectively (Harper and LoGrasso,
2001
; Kyriakis and Avruch,
2001
).
How lack of oxygen, i.e. anoxia and ischemia affect ERK signalling has been
the subject for a number of studies. However, most studies have focussed on
specialised mammalian tissues, such as cardiovascular cell types, specialised
epithelial cells and neurons. In the whole rat heart, ERK2 is inactivated in
response to ischemia, followed by translocation of the inactive kinase to the
nuclear compartment (Mizukami and Yoshida,
1997
). Interestingly, ERK2 was activated in response to
reperfusion, suggesting an interface capable of ERK activation in the nuclear
membrane. Using the rat myocyte cell line H9c2, which has been shown to
display ERK activities similar to those seen in whole organs during oxidative
and metabolic stress (Abas et al.,
2000
), it was demonstrated that the ischemic nuclear translocation
of ERK2 was dependent on both phosphatidyl inositol 3-kinase (PI 3-kinase) and
the atypical protein kinase C (PKC) isoform PKC
(Mizukami et al., 1997
;
Mizukami et al., 2000
).
Hypoxia also stimulates ERK1/2 phosphorylation in vascular smooth muscle cells
(Blaschke et al., 2002
). To our
knowledge, there are no studies on the effect of anoxia on ERK signalling in
fish cells.
Previously, we demonstrated a rapid, but transient activation of
p38MAPK during chemical anoxia in rainbow trout hypodermal
fibroblasts (RTHDF) (Ossum et al.,
2004
). Such an activation of p38MAPK by anoxic insults
have previously been reported in perfused hearts
(Bogoyevitch et al., 1996
;
Nakano et al., 2000
),
ventricular myocytes (Saurin et al.,
2000
), H9c2 cells (Jung et
al., 2004
) and in neuronal tissues
(Conrad et al., 1999
;
Harper and LoGrasso, 2001
;
Zhu et al., 2002
). These
studies demonstrate multiple functions of p38MAPK. In PC12 cells,
activation of p38MAPK inhibits expression of cyclin D1
(Conrad et al., 1999
) and in
primary neurons, p38MAPK stabilises p53 and inhibits transformed
mouse 3T3 cell double minute 2 (Mdm2) (Zhu
et al., 2002
). Studies of vascular tissue demonstrate activation
of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP K-2)
downstream of p38MAPK
(Bogoyevitch et al., 1996
;
Nakano et al., 2000
). In
primary rat astrocytes, p38MAPK signalling has been implicated in
induction of Hsp70 (Uehara et al.,
1999
). Together, these studies demonstrate roles for
p38MAPK in both cell death and protection. There are several
observations showing cross-talk between p38MAPK and ERK (e.g.
Singh et al., 1999
). Thus it
is probable that the observed activation of p38MAPK could be
followed by an inhibition of ERK.
The present study was initiated to determine the effects of chemical
anoxia, as well as nitrogen-induced anoxia and recovery on p44ERK activity in
RTHDF (Ossum et al., 2004
),
originating from the rainbow trout Oncorhynchus mykiss L. Here, we
report that both chemical anoxia induced by sodium azide, as well as true
anoxia (PO2<0.1%) result in inhibition of p44ERK during
azide treatment and that p44ERK is dramatically activated in response to
recovery. In the chemical anoxia model we find that inhibition of p44ERK
activity during anoxia is dependent on p38MAPK activity, whereas
its activation during recovery is positively regulated by reactive oxygen
species and a calyculin A-sensitive serine/threonine phosphatase. A proposed
model describing ERK regulation during anoxia and recovery in RTHDF cells is
presented.
| Materials and methods |
|---|
|
|
|---|
Cell culture
Rainbow trout (Oncorhynchus mykiss L.) hypodermal fibroblasts
(RTHDF) were cultured in Leibovitz' L-15, supplemented with 15% (v/v) foetal
bovine serum (FBS), penicillin (100 i.u. ml1) and
streptomycin (100 µg ml1) at 21°C and atmospheric
air, as described previously (Ossum et
al., 2004
). Trypsin solution for cell detachment was made by
dissolving 0.1% (w/v) trypsin and 1 mmol l1 disodium EDTA in
phosphate-buffered saline (PBS: 137 mmol l1 NaCl, 2.7 mmol
l1 KCl, 8.1 mmol l1
Na2HPO4, 1.5 mmol l1
KH2PO4) (Ma and
Collodi, 1999
). All cell culture reagents were used cold from the
refrigerator.
All cell culture plastic ware was from TPR (Trasadingen, Switzerland).
Experimental conditions
Experiments were performed with cells grown to approximately 80% confluency
in six well plates throughout. Cells were plated 12 days prior to
experiments.
During experiments, cells were incubated in L15ex, consisting of 140 mmol
l1 NaCl, 5 mmol l1 KCl, 2 mmol
l1 MgCl2, 1 mmol l1
MgSO4, 1 mmol l1 Na2HPO4,
0.4 mmol l KH2PO4, 1 mmol
l1 CaCl2, 5 mmol l galactose,
10 mmol l Hepes and 5 mmol l1 sodium
pyruvate (Ossum et al., 2004
;
Schirmer et al., 1997
). Anoxia
was induced using L-15ex in which 10 mmol l1 NaCl was
replaced with 10 mmol l1 sodium azide (NaN3).
Osmolality was measured and found to 304 and 305 mOsm kg1
for L-15ex and L-15ex with sodium azide, respectively. Recovery
(reoxygenation) occurred by washing the cells twice in PBS, and then
incubating in L-15ex without NaN3.
Nitrogen-induced anoxia was obtained by keeping the Leibowitz' L15 medium with supplements in an airproof chamber under a constant flow of N2 until anoxia was obtained as registered by an oxygen-sensitive probe. The cells were then exposed to this now anoxic medium while keeping a constant flow of N2. Recovery (reoxygenation) occurred by removing the cells from the anoxic chamber, then washing the cells twice in PBS and incubating in Leibovitz' L-15ex. Under anoxic conditions, oxygen concentration never exceeded 0.1%.
Cells were serum starved by overnight incubation in Leibovitz' L-15 basal medium, supplemented with antibiotics and 0.1% FBS, where indicated. Serum stimulation was performed by exposing cells to 20% FBS.
When indicated, cells were pre-incubated for 1 h in the presence of 10 µmol l1 SB203580, 10 or 30 µmol l1 PD98059 and 100 nmol l1 DPI. PD98059 was added to the recovery medium at 10 µmol l1 final concentration. Calyculin A was applied for 2 min at 100 nmol l1 final concentration.
SDS-PAGE and western blot analysis
Cells were rinsed once in ice cold PBS and harvested by scraping in 100
µl boiling SDS lysis buffer [1% (v/v) SDS, 1 mmol l1
Na3VO4 (from a 200 mmol l stock
solution), 10 mmol l1 Tris, pH 7.4]. Extracts were
homogenised by sonication, followed by removal of cell debris by
centrifugation at 16 000 g for 5 min. Protein concentration
was determined spectrophotometrically using the detergent-compatible protein
assay Bio-Rad DC Protein Assay Kit and BSA as a standard. Samples for
electrophoresis were prepared by adding NuPAGE LDS sample buffer from a
4x stock solution (cat. no. NP0007) supplemented with 10% (v/v) 0.5 M
dithiothreitol (DTT), then boiling for 5 min. Proteins were separated by
SDS-PAGE, using precast NuPAGE 10% Bis-Tris gels (cat. no. NP0302BOX) and
electrotransferred to nitrocellulose membranes of 0.22 µm pore size (cat.
no. LC2000), using NuPAGE Mops SDS running buffer (cat. no. NP0001) and NuPAGE
transfer buffer (cat. no. NP0006-1), respectively. The gels were loaded with
1520 µg protein per lane. Equal gel loading and successful transfer
of proteins were checked by staining membranes with Ponseau S [0.1% Ponseau S
(w/v) 5% acetic acid (v/v)]. Electrophoresis and transfer were performed using
the XCell SureLock and the XCell II Blot module (Invitrogen, cat. no. E10002),
respectively. After transfer, the nitrocellulose membrane was incubated in
blocking buffer [5% non-fatty dry milk in TBS-T (10 mmol l1
Tris-HCl, pH 7.5, 120 mmol l1 NaCl and 0.1% Tween20)] for 1
h at room temperature (RT) or overnight (ON) at 4°C. Primary antibodies
were applied for 1 h at room RT or ON at 4°C. The membrane was then washed
three times in TBS-T for 515 min. The secondary, alkaline phosphatase
conjugated antibody was applied for 1 h at RT, followed by washing as
described above. Immunoreactive bands were detected using BCIP/NBT. The bands
were quantified using a HP Scanjet 4600 (Hewlett Packard Palo Alto, CA, USA)
and the software UN-SCAN-IT gel version 5.1 for Windows (Silk Scientific Corp.
UT, USA). UN-SCAN-IT gel version 5.1 was also used for estimation of molecular
mass.
The primary antibodies against p44ERK, p44/42 MAP kinase antibody (cat. no. 9102) and phospho-p44/42 MAP kinase (Thr202/Tyr204) antibody (cat. no. 9101) were diluted 1:1000 in blocking buffer. The phospho-MEK1/2 (Ser217/221) antibody (cat. no. 9121) was diluted 1:500. The secondary antibody was diluted 1:500.
Statistical analyses
Western blot quantification data were statistically analyzed by two-tailed,
unpaired Student's t-tests. P<0.05 was regarded as
significant. Quantified results are presented as relative numbers ±
s.d. Estimated molecular masses are given as mean ± s.d. N
indicates the number of independent experiments.
| Results |
|---|
|
|
|---|
|
Interestingly, these two isoforms displayed different phosphorylation profiles in response to serum stimulation. Both p44ERK and p38ERK were rapidly activated by serum stimulation of serum starved RTHDF cells. Maximal phosphorylation was observed after 5 min. For p44ERK, there was no detectable difference in the phosphorylation levels between 5 and 10 min of FBS stimulation. After the peak in activity, the phosphorylation level gradually declined. However, p44ERK was still significantly activated after 30 min. The p38ERK isoform demonstrated a biphasic activity. The level of phosphorylation peaked at 5 min, followed by a decrease until 15 min. After 20 min in the presence of FBS, a new peak in p38ERK phosphorylation was observed. The total p44ERK protein did not decay under any of the conditions (Fig. 1A, lower panel).
Dose-dependent inhibition of p44 ERK activity by sodium azide
Sodium azide (NaN3) treatment is an established model for
induction of chemical anoxia
(Jørgensen et al.,
1999
; Ossum et al.,
2004
; Varming et al.,
1996
). To test the effect of chemical anoxia on p44ERK signalling,
RTHD fibroblasts were treated with increasing concentrations of
NaN3 for 30 min and the phosphorylation status of p44ERK was
assayed by western blotting (Fig.
2). The ERK activity (phosphorylation) was inhibited in a
dose-dependent manner.
|
Time-dependent changes in p44ERK phosphorylation during chemical anoxia and recovery
The time-course of p44ERK activity in RTHDF cells during chemical anoxia
and recovery (A/R) was examined. Chemical anoxia was induced by 10 mmol
l1 NaN3. We observed a gradual decrease in p44ERK
phosphorylation (Fig. 3A),
statistically significant after 30 min incubation with sodium azide. Upon
recovery, p44ERK was rapidly phosphorylated and the level of phosphorylation
continued to increase during 1 h recovery
(Fig. 3B). Significant
activation of p44ERK was observed after 10 min recovery. The effect of
recovery was strongly inhibited when 10 µmol l1 final
concentration of the MEK1/2 inhibitor PD98059 was added to the medium during
recovery (Fig. 4).
|
|
Time-dependent changes in p44ERK phosphorylation during nitrogen-induced anoxia and recovery
The anoxia experiment was repeated using nitrogen to displace oxygen
(Fig. 5). The level of p44ERK
phosphorylation slowly decreased, resulting in significant inhibition after 3
h, comparable to the significant decrease after 30 min chemical anoxia. During
recovery, phosphorylation of p44ERK occurred faster than in azide-treated
cells, with significant and robust activation after 5 min. After 30 min, the
level of ERK phosphorylation decreased and reached a plateau that was stable
throughout the experiment.
|
/ß-specific inhibitor
(English and Cobb, 2002
|
|
Raf-1 is dispensable for stimulation of p44ERK during recovery from chemical anoxia
The S/T kinase Raf-1 is the archetypical MAP3K in the ERK cascade
(Kyriakis and Avruch, 2001
;
Widmann et al., 1999
), and is
known to be derepressed by dephosphorylation
(Ory et al., 2003
). To clarify
the involvement of Raf-1 in recovery-mediated activation of p44ERK, RTHDF
cells were either serum starved and stimulated with FBS or subjected to
anoxia/recovery in the absence or presence of 10 µmol l1
Raf1 kinase inhibitor I (RKI). Inhibition of Raf-1 strongly inhibited
serum-stimulated phosphorylation of p44ERK in starved cells
(Fig. 8A). However, RKI did not
affect phosphorylation of p44ERK during recovery from chemical anoxia
(Fig. 8B).
|
|
Changes in p44ERK phosphorylation during anoxia/recovery are dependent on MEK
The effect of A/R on MEK activity in RTHD fibroblasts was analysed by
western blotting and detection of phosphorylated MEK1/2. Paralleling p44ERK,
MEK phosphorylation was inhibited by anoxia and stimulated above normoxic
levels by recovery (Fig. 10A).
When RTHDF cells were incubated with the
p38MAPK
/ß-specific inhibitor SB203580
(English and Cobb, 2002
) for 1
h prior to the anoxic insult, inhibition of MEK by chemical anoxia was
prevented (Fig. 10B).
Similarly, incubation with 100 nmol l1 calyculin A for 2 min
prior to A/R prevented reactivation of MEK during recovery
(Fig. 10C).
|
| Discussion |
|---|
|
|
|---|
The p44- and p38ERK proteins responded to serum stimulation following overnight serum starvation. Interestingly, they differed in their activation profile within the 30 min time frame used in this study. p44ERK was activated approximately threefold after 510 min in the presence of FBS followed by a decreasing level of phosphorylation. By contrast, p38ERK was regulated in a biphasic manner in response to FBS. After 5 min, p38ERK was phosphorylated sevenfold, with respect to serum starved cells. This was followed by a decreasing level of phosphorylation, reaching a minimum after 15 min before peaking again at 20 min.
Our observations are consistent with a study of peripheral blood
lymphocytes from red drum, Sciaenops ocellatus L. and channel cat
fish, Ictalurus punctatus R., demonstrating the presence of
PMA-sensitive ERK proteins of 43 and 46 kDa
(MacDougal et al., 1999
).
Furthermore, p38ERK is probably the same molecule as the
H2O2-responsive, 38 kDa ERK-like protein observed in the
rainbow trout hepatoma cell line RTH 149
(Burlando et al., 2003
).
Together with these studies, our data points to the existence of divergent
ERK-like proteins among fishes.
We and others have previously used 10 mmol l1 sodium
azide as an inducer of chemical anoxia
(Jørgensen et al.,
1999
; Ossum et al.,
2004
; Varming et al.,
1996
). In our previous study of chemical anoxia in RTHD
fibroblasts (Ossum et al.,
2004
) a regime of 30 min of anoxia was established. Using this
time period, a dose-dependent inhibition of basal ERK activity by sodium azide
was found.
In the present study, it was demonstrated that chemical anoxia results in a
time-dependent dephosphorylation of p44ERK in RTHDF cells, statistically
significant after 30 min. Upon recovery, p44ERK was rapidly phosphorylated.
Significant phosphorylation, with respect to anoxic cells, was observed after
10 min recovery. After 60 min recovery, the phosphorylation of p44ERK is six
times higher than in anoxic cells. Activation of p44ERK is MEK dependent, as
demonstrated using PD98059, which is a pharmacological inhibitor of MEK1/2
(English and Cobb, 2002
). A
similar decrease in ERK activity during cyanide-induced anoxia was observed,
using the heart-derived, myogenic rat cell line H9c2
(Jung et al., 2004
).
To validate chemical anoxia as a substitute for real oxygen deprivation, the anoxia/recovery experiment was repeated using nitrogen to displace oxygen. The same gradual inhibition of p44ERK during anoxia and phosphorylation during recovery were observed. However, the inhibition of p44ERK in response to nitrogen-induced anoxia was slower, resulting in significant inhibition only after 3 h. During recovery, phosphorylation of p44ERK occurred faster than in azide-treated cells, with significant and robust activation after 5 min. After 30 min, the level of ERK phosphorylation decreased and reached a plateau that was stable throughout the experiment. A similar, stable plateau level was observed in a single experiment with chemical anoxia (data not shown). We conclude that sodium azide can substitute for real anoxia in this experimental setting and that azide-induced anoxia has a stronger and more lasting effect compared to the removal of O2 using nitrogen.
During anoxia, induced by both azide and nitrogen there was a trend towards an initial stimulation of p44ERK at 5 and 10 min, however, not statistically significant in either situation.
In a previous study we demonstrated a rapid, but transient activation of
the stress-responsive p38MAPK in RTHDF cells
(Ossum et al., 2004
). The
physiological significance of this observation, however, was not clear. In the
present study, we obtained data indicating that activation of
p38MAPK is necessary for attenuation of p44ERK signalling and
involves the dephosphorylation of MEK.
The observation that p38MAPK activity is sufficient to attenuate
ERK signalling is consistent with recent studies
(Ding and Adrian, 2001
;
Jung et al., 2004
;
Lee et al., 2002
;
Li et al., 2003
;
Liu and Hofmann, 2004
;
Singh et al., 1999
;
Westermarck et al., 2001
). In
the very first report observing p38MAPK-to-ERK cross-talk, it was
shown that inhibition of p38
/ß by SB203585 alone is sufficient to
induce expression of low density lipoprotein receptor via activation of the
ERK1/2 pathway in HepG2 cells (Singh et
al., 1999
). Further studies demonstrated that exposure of human
skin fibroblasts to arsenite or adenoviral transduction of a constitutive
active allele of MKK3b blocked ERK signalling
(Li et al., 2003
;
Westermarck et al., 2001
).
Using H9c2 cells, Jung et al. (Jung et
al., 2004
) observed activation of JNK and p38MAPK with
the concurrent inhibition of ERK, using cyanide as a metabolic inhibitor.
Also, a similar p38MAPK-dependent mechanism has been described for
induction of cell cycle arrest in myoblasts committed to differentiation
(Lee et al., 2002
). Lee et al.
demonstrated that both the p38
/ß-inhibitor, SB203580, and a
dominant negative mutant of MKK6 inhibit differentiation and result in
activation of the Raf/MEK/ERK pathway and subsequent proliferation. Finally,
p38MAPK-dependent signalling was discovered to inhibit stimulation
of ERK1/2 in rat ventricular myocytes during
H2O2-induced apoptosis
(Liu and Hofmann, 2004
). These
studies, together with the present data, might suggest that p38MAPK
is involved in regulatory mechanisms converging at ERK, which are common to
environmental and physiological stimuli. This is shown schematically in
Fig. 11, middle panel.
|
There is clear evidence in the literature that the calyculin A-sensitive
phosphatases PP1 and/or PP2A can affect the MAPK pathway via
different mechanisms specified by the cellular context
(Janssens and Goris, 2001
;
Millward et al., 1999
;
Silverstein et al., 2002
).
Accumulating evidence strongly indicate a role for PP1/PP2A in inhibition of
ERK signalling (Alessi et al.,
1995
; Goméz and Cohen,
1991
; Liu and Hofmann,
2004
; Westermarck et al.,
2001
). However, to our knowledge, only a few prior studies
demonstrate a role for PP2A in stimulation of the mammalian ERK1/2 pathway.
PP1/PP2A was shown to be a positive regulator of the kinase Raf-1 in
vivo (Abraham et al.,
2000
; Mitsuhashi et al.,
2003
). PP2A seems to stimulate Raf/MEK/ERK signalling by
dephosphorylating binding sites for 14-3-3 proteins, which are involved in
suppression of Raf-1 and the scaffold protein kinase suppressor of Ras (KSR)
(Ory et al., 2003
). The
present inhibitor studies, however, demonstrated that Raf-1 is dispensable for
phosphorylation of p44ERK during recovery of RTHDF cells. By contrast,
inhibition of Raf-1 prevented FBS-induced p44ERK phosphorylation in
serum-starved RTHD fibroblasts. We, therefore, suggest that a
calyculin-sensitive S/T phosphatase activity is necessary for activation of
p44ERK during recovery from chemical anoxia. However, the identity of the
presumptive phosphatase and its pathway are currently unknown and requires
further studies.
Our data indicate that p44ERK phosphorylation during recovery is critically
dependent on ROS-mediated signalling. Activation of p44ERK following removal
of sodium azide was blocked by pre-treatment with DPI. This result strongly
suggests that a NAD(P)H oxidase-like enzyme is involved in intracellular ROS
production. Owing to their small size, diffusion properties and controllable
production, reactive oxygen derivatives are ideally suited for a role as
second messengers (Hancock et al.,
2001
). An appealing notion is that, in response to extreme
environmental changes, production of ROS could represent a mechanism for rapid
and robust ERK signalling. When relieved from potentially lethal anoxic stress
conditions, NAD(P)H oxidase-mediated ERK activation could prevent cell death
by stimulating survival pathways and antagonising apoptotic signalling.
Indeed, low activity NAD(P)H oxidase homologues, e.g. NOX enzymes, which act
as signalling molecules but not for host defence, are shown to be present in a
variety of non-phagocytic cells (Babior,
1999
; Lambeth,
2004
). Mitogenic signalling has been shown to be mediated by ROS
in Ras-transformed NIH 3T3 cells (Irani et
al., 1997
) and evidence suggests that non-phagocytic cells have
the ability to regulate ROS production according to changes in
PO2 (Jones et al.,
2000
). Furthermore, H2O2 seems to regulate a
genetic programme involving a large number of genes associated with signal
transduction and cell cycle progression
(Arnold et al., 2001
). The
latter observation is in agreement with the findings that generation of
superoxide is involved in activation of nuclear factor kappa B (NF-
B)
by platelet-derived growth factor (PDGF)
(Marumo et al., 1997
;
Sun and Oberley, 1996
) and
AP-1 (Sun and Oberley, 1996
).
Our observations, taken together with the above studies and the fact that
H2O2 is an established ERK activator in various
mammalian systems, support a role for NAD(P)H oxidase as a mediator of rapid
responses to changes in oxygen availability.
The signalling molecules downstream of the NAD(P)H oxidase-like enzyme and
upstream of p44ERK are currently unknown. A working model is presented in
Fig. 11, right panel. We
speculate that ROS-mediated activation of p44ERK occurs by a pathway including
the c-Src family of protein tyrosine kinases and PKC to MEK via
MEKK1. Supporting this notion is the findings that hypoxia/recovery and
oxidative stress, elicited by H2O2 activate Src-family
kinases upstream of ERK (Aikawa et al.,
1997
; Seko et al.,
1996
; Suzaki et al.,
2002
). PKCß has been shown to be activated by ROS and to
functionally interact with MEKK1 (Datta et
al., 2000
; Kaneki et al.,
1999
) and MEKK1 is a known MEK kinase in the ERK pathway
(Hagemann and Blank, 2001
). As
well, PKC
has been shown to trigger Ras and Raf-independent MEK/ERK
activation in HepG2 cells (Wen-Sheng,
2005
). In addition, H2O2 stimulation of
COS-7 cells results in tyrosine phosphorylation and activation of the
classical PKC isoforms
, ßI and
, the novel PKC isoforms
and
and the atypical PKC isoform PKC
(Konishi et al., 1997
).
Finally, H2O2 has been implicated in ligand-independent
activation of the platelet-derived growth factor receptor ß by a
mechanism depending on c-Src and PKC
(Saito et al., 2002
). In the
studies of Datta (Datta, 2000) and Kaneki (Kaneki, 1999), MEKK1 stimulated
JNK. However, JNK was not activated in our system either by chemical anoxia or
recovery (K. Krogh-Jeppesen, C.G.O. and E.K.H., unpublished results). Thus we
speculate that MEKK1 may be the MAP3K responsible for the observed
phosphorylation of p44ERK during recovery.
In conclusion, we have described a 44 kDa p44ERK protein in RTHDF cells. When cells are challenged with chemical anoxia, phosphorylation of p44ERK was inhibited secondary to activation of p38MAPK-dependent mechanism. Recovery resulted in robust upregulation of p44ERK activity, in a PP1/PP2A- and ROS-dependent manner. A similar, but slower inhibition and a similar, but faster recovery of pp44ERK was seen under nitrogen-induced anoxia.
| List of abbreviations |
|---|
|
|
|---|
B
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Abas, L., Bogoyevitch, M. A. and Guppy, M. (2000). Mitochondrial ATP production is necessary for activation of the extracellular-signal-regulated kinases during ischaemia/reperfusion in rat myocyte-derived H9c2 cells. Biochem. J. 349,119 -126.[CrossRef][Medline]
Abraham, D., Podar, K., Pacher, M., Kubicek, M., Welzel, N.,
Hemmings, B. A., Dilworth, S. M., Mischak, H., Kolch, W. and Baccarin,
M. (2000). Raf-1-associated protein phosphatase 2A as a
positive regulator of kinase activation. J. Biol.
Chem. 275,22300
-22304.
Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Tanaka, M., Shiojima, I., Hiroi, Y. and Yazaki, Y. (1997). Oxidative stress activates extracellular signalregulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest. 100,1813 -1821.[Medline]
Alessi, D. R., Gomez, N., Moorhead, G., Lewis, T., Keyse, S. and Cohen, P. (1995). Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100 in various cell lines. Curr. Biol. 5, 283-295.[CrossRef][Medline]
Allan, L. A., Morrice, N., Brady, S., Magee, G., Pathak, S. and Clarke, P. R. (2003). Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat. Cell Biol. 5,647 -654.[CrossRef][Medline]
Arnold, R. S., Shi, J., Murad, E., Whalen, A. M., Sun, C. Q.,
Polavarapu, R., Parthasarathy, S., Petros, J. A. and Lambeth, J. D.
(2001). Hydrogen peroxide mediates the cell growth and
transformation caused by the mitogenic oxidase Nox1. Proc. Natl.
Acad. Sci. USA 98,5550
-5555.
Babior, B. M. (1999). NADPH oxidase: an update.
Blood 93,1464
-1476.
Barr, R. K. and Bogoyevitch, M. A. (2001). The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases. Int. J. Biochem. Cell Biol. 33,1047 -1063.[CrossRef][Medline]
Blaschke, F., Stawowy, P., Goetze, S., Hintz, O., Gräfe, M., Kintscher, U., Fleck, E. and Graf, K. (2002). Hypoxia activates ß1-integrin via ERK1/2 and p38 MAP kinase in human vascular smooth muscle cells. Biochem. Biophys. Res. Comm. 296,890 -896.[CrossRef][Medline]
Bogoyevitch, M. A., Gillespie-Brown, J., Ketterman, A. J.,
Fuller, S. J., Ben-Levy, R., Ashworth, A., Marshall, C. J. and Sugden,
P. H. (1996). Stimulation of the stress-activated
mitogen-activated protein kinase subfamilies in perfused heart.
Circ. Res. 79,162
-173.
Burlando, B., Magnelli, V., Panfoli, I., Berti, E. and Viarengo, A. (2003). Ligand-independent tyrosine kinase signalling in RTH 149 trout hepatoma cells: Comparision among heavy metals and pro-oxidants. Cell. Physiol. Biochem. 13,147 -154.[CrossRef][Medline]
Cano, E. and Mahadevan, L. C. (1995). Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20,117 -121.[CrossRef][Medline]
Cerioni, L., Palomba, L. and Cantoni, O. (2003). The Raf/MEK inhibitor PD98059 enhances ERK1/2 phosporylation mediated by peroxynitrite via enforced mitochondrial formation of reactive oxygen species. FEBS Lett. 547, 92-96.[CrossRef][Medline]
Conrad, P. W., Rust, R. T., Han, J., Millhorn, D. E. and
Beitner-Johnson, D. (1999). Selective activation of
p38
and p38
by hypoxia. J. Biol. Chem.
274,23570
-23576.
Cowan, K. J. and Storey, K. B. (2003).
Mitogen-activated protein kinases: new signaling pathways functioning in
cellular responses to environmental stress. J. Exp.
Biol. 206,1107
-1115.
Datta, R., Yoshinaga, K., Kaneki, M., Pandey, P. and Kufe,
D. (2000). Phorbol ester-induced generation of reactive
oxygen species is protein kinase Cß-dependent and required for SAPK
activation. J. Biol. Chem.
275,41000
-41003.
Ding, X.-Z. and Adrian, T. E. (2001). MEK/ERK-mediated proliferation is negatively regulated by p38 MAP kinase in the human pancreatic cancer cell line, PANC-1. Biochem. Biophys. Res. Comm. 282,447 -453.[CrossRef][Medline]
Dröge, W. (2002). Free radicals in the
physiological control of cell function. Physiol. Rev.
82, 47-95.
English, J. M. and Cobb, M. H. (2002). Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 23,40 -45.[CrossRef][Medline]
Goméz, N. and Cohen, P. (1991). Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 353,170 -173.[CrossRef][Medline]
Goyal, P., Weissmann, N., Grimminger, F., Hegel, C., Bader, L., Rose, F., Fink, L., Ghofrani, H. A., Schermuly, R. T., Schmidt, H. H. et al. (2004). Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia inducible factor 1 via increase in reactive oxygen species. Free Radic. Biol. Med. 36,1279 -1288.[CrossRef][Medline]
Guyton, K. Z., Liu, Y., Gorospe, M., Xu, Q. and Holbrook, N.
J. (1996). Activation of mitogen-activated protein kinase by
H2O2. J. Biol. Chem.
271,4138
-4142.
Hagemann, C. and Blank, J. L. (2001). The ups and downs of MEK kinase interactions. Cell. Signal. 13,863 -875.[CrossRef][Medline]
Hancock, J. T., Desikan, R. and Neill, S. J. (2001). Role of reactive oxygen species in cell signalling pathways. Biochem. Soc. Trans. 29,345 -350.[CrossRef][Medline]
Harper, S. J. and LoGrasso, P. (2001). Signalling for survival and death in neurons. The role for stress-activated kinases, JNK and p38. Cell. Signal 13,299 -310.[CrossRef][Medline]
Honkanen, R. E. and Golden, T. (2002). Regulators of serine/threonine protein phosphatases at the dawn of a clinical era? Curr. Med. Chem. 9,2055 -2075.[Medline]
Irani, K., Xia, Y., Zweier, Y. L., Sollott, S. J., Der, C. J.,
Fearon, E. R., Sundaresan, M., Finkel, T. and Goldschmidt-Clermont, P.
J. (1997). Mitogenic signaling mediated by oxidants in
Ras-transformed fibroblasts. Science
275,1649
-1652.
Janssens, V. and Goris, J. (2001). Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and singallin. Biochem. J. 353,417 -439.[CrossRef][Medline]
Jin, K., Mao, X. O., Zhu, Y. and Greenberg, D. A. (2002). MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad. J. Neurochem. 80,119 -125.[CrossRef][Medline]
Jones, R. D., Hancock, J. T. and Morice, A. H. (2000). NADPH oxidase: a universal oxygen sensor? Free Radic. Biol. Med. 29,416 -424.[CrossRef][Medline]
Jørgensen, N. K., Pedersen, S. F., Damgaard, I., Schousboe, A. and Hoffmann, E. K. (1999). Increases in [Ca2+]i and changes in intracellular pH during chemical anoxia in mouse neocortical Neurons in primary culture. J. Neurosci. Res. 56,358 -370.[CrossRef][Medline]
Jung, Y.-S., Jung, Y.-S., Kim, M.-Y. and Kim, E.
(2004). Identification of caspase-independent PKC
-JNK/p38
MAPK signaling module in response to metabolic inhibition in H9c2 cells.
Jpn. J. Physiol. 54,23
-29.[CrossRef][Medline]
Kaneki, M., Kharbanda, S., Pandey, P., Yoshida, K., Takekawa,
M., Liou, J.-R., Stone, R. and Kufe, D. (1999).
Functional role for protein kinase Cß as a regulator of stress-activated
protein kinase activation and monocytic differentiation of myeloid leukemia
cells. Mol. Cell. Biol.
19,461
-470.
Konishi, H., Tanaka, M., Takemura, Y., Matsuzaki, H., Ono, Y.,
Kikkawa, U. and Nishizuka, Y. (1997). Activation of
protein kinase C by tyrosine phosphorylation in response to
H2O2. Proc. Natl. Acad. Sci. USA
94,11233
-11237.
Kyriakis, J. M. and Avruch, J. (2001).
Mammalian mitogen-activated protein kinase signal transduction pathways
activated by stress and inflammation. Physiol. Rev.
81,807
-869.
Lambeth, J. D. (2004). NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181-189.[CrossRef][Medline]
Lee, J., Hong, F., Kwon, S., Kim, S. S., Kim, O. D., Kang, S. H., Lee, S. J., Ha, J. and Kim, S. S. (2002). Activation of p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation. Biochem. Biophys. Res. Comm. 289,765 -771.
Li, S.-P., Junttila, M. R., Han, J., Kähäri, V.-M. and
Westermarck, J. (2003). p38 mitogen-activated protein kinase
pathway suppresses cell survival by inducing dephosphorylation of
mitogen-activated protein/extracellular signal-regulated kinase kinase 1,2.
Cancer Res. 63,3473
-3477.
Liu, Q. and Hofmann, P. A. (2004). Protein phosphatase 2A-mediated crosstalk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am. J. Physiol. 286,H2204 -H2212.
Ma, C. and Collodi, P. (1999). Preparation of primary cells from lamprey. Methods Cell Sci. 21, 39-46.[CrossRef][Medline]
MacDougal, K. C., Mericko, P. A. and Burnett, K. G. (1999). Antigen receptor-mediated activation of extracellular related kinase (ERK) in B lymphocytes of teleost fishes. Dev. Comp. Immunol. 23,221 -230.[CrossRef][Medline]
Marumo, T., Schini-Kerth, V. B., Fisslthaler, B. and Busse,
R. (1997). Platelet-derived growth factor stimulated
superoxide anion production modulates activation of transcription factor
NF-
B and expression of monocyte chemoattractant protein 1 in human
aortic smooth muscle cells. Circulation
96,2361
-2367.
Matsui, T., Suzuki, Y., Yamashita, K., Yoshimaru, T., Suzuki-Karasaki, M., Hayakawa, S., Yamaki, M. and Shimizu, K. (2000). Diphenyleneiodonium prevents reactive oxygen species generation, tyrosine phosphorylation, and histamine release in RBL-2H3 mast cells. Biochem. Biophys. Res. Comm. 276,742 -748.[CrossRef][Medline]
Millward, T. A., Zolnierowicz, S. and Hemmings, B. A. (1999). Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24,186 -191.[CrossRef][Medline]
Mitsuhashi, S., Shima, H., Tanuma, N., Matsuura, N., Takekawa,
M., Urano, T., Kataoka, T., Ubukata, M. and Kikuchi, K.
(2003). Usage of tautomycetin, a novel inhibitor of protein
phosphatase 1 (PP1), reveals that PP1 is a positive regulator of Raf-1 in
vivo. J. Biol. Chem. 278,82
-88.
Mizukami, Y. and Yoshida, K. I. (1997). Mitogen-activated protein kinase translocates to the nucleus during ischemia and is activated during reperfusion. Biochem. J. 323,785 -790.[Medline]
Mizukami, Y., Hirata, T. and Yoshida, K. I.
(1997). Nuclear translocation of PKC
during ischemia and
its inhibition by wortmannin, an inhibitor of phosphatidylinositol 3-kinase.
FEBS Lett. 401,247
-251.[CrossRef][Medline]
Mizukami, Y., Kobayashi, S., Überall, F., Hellbert, K.,
Kobayashi, N. and Yoshida, K. I. (2000). Nuclear
mitogen-activated protein kinase activation by protein kinase C
during
reoxigenation after ischemic hypoxia. J. Biol. Chem.
275,19921
-19927.
Nakano, A., Baines, C. P., Kim, S. O., Pelech, S. L., Downey, J.
M., Cohen, M. V. and Critz, S. D. (2000). Ischemic
preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for
involvement of p38 MAPK. Circ. Res.
86,144
-151.
New, L. and Han, J. (1998). The p38 MAP kinase pathway and its biological function. Trends Cardiovasc. Med. 8,220 -229.[CrossRef][Medline]
Nikinmaa, M. (2002). Oxygen-dependent cellular functions why fishes and their aquatic environment are a prime choice of study. Comp. Biochem. Physiol. 133A, 1-16.[CrossRef][Medline]
O'Donnell, B. V., Tew, D. G., Jones, O. T. and England, P. J. (1993). Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem. J. 290,41 -49.[Medline]
Ory, S., Zhou, M., Conrads, T. P., Veenstra, T. D. and Morrison, D. K. (2003). Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr. Biol. 13,1356 -1364.[CrossRef][Medline]
Ossum, C. G., Hoffmann, E. K., Vijayan, M. M., Holt, S. E. and Bols, N. C. (2004). Characterization of a novel fibroblast-like cell line from rainbow trout and responses to sublethal anoxia. J. Fish Biol. 64,1103 -1116.[CrossRef]
Saito, S., Frank, G. D., Mifune, M., Ohba, M., Utsunomiya, H.,
Motley, E. D., Inagami, T. and Eguchi, S. (2002).
Ligand-independent trans-activation of the platelet-derived growth
factor by reactive oxygen species requires protein kinase C-
and c-Src.
J. Biol. Chem. 277,44695
-44700.
Saurin, A. T., Martin, J. L., Heads, R. J., Foley, C.,
Mockridge, J. W., Wright, M. J., Wang, Y. and Marber, M. S.
(2000). The role of differential activation of
p38-mitogen-activated protein kinase in preconditioned ventricular myocytes.
FASEB J. 14,2237
-2246.
Schaeffer, H. J. and Weber, M. J. (1999).
Mitogen-activated protein kinases: specific messages from ubiquitous
messengers. Mol. Cell. Biol.
19,2435
-2444.
Schirmer, K., Chan, A. G. J., Greenberg, M. B., Dixon, D. G. and Bols, N. C. (1997). Methodology for demonstrating and measuring the photocytotoxicity of fluoranthene to fish cells in culture. Toxicol. Vitro 11,107 -109.[CrossRef]
Schmitz, M. L., Bacher, S. and Dröge, W. (2002). Molecular analysis of mitogen-activated protein kinase signaling pathways induced by reactive oxygen intermediates. Methods Enzymol. 352,53 -61.[Medline]
Seko, Y., Tobe, K., Takahashi, N., Kaburagi, Y., Kadowaki, T. and Yazaki, Y. (1996). Hypoxia and hypoxia/reo